Literature DB >> 8364206

Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q.

S Gibson1, B Leung, J A Squire, M Hill, N Arima, P Goss, D Hogg, G B Mills.   

Abstract

Signal transduction through the T-cell receptor and cytokine receptors on the surface of T lymphocytes occurs largely via tyrosine phosphorylation of intracellular substrates. Because neither the T-cell receptor nor cytokine receptors contain intrinsic kinase domains, signal transduction is thought to occur via association of these receptors with intracellular protein tyrosine kinases. Although several members of the SRC and SYK families of tyrosine kinases have been implicated in signal transduction in lymphocytes, it seems likely that additional tyrosine kinases involved in signal transduction remain to be identified. To identify unique T-cell tyrosine kinases, we used polymerase chain reaction-based cloning with degenerate oligonucleotides directed at highly conserved motifs of tyrosine kinase domains. We have cloned the complete cDNA for a unique human tyrosine kinase that is expressed mainly in T lymphocytes (EMT) and natural killer (NK) cells. The cDNA of EMT predicts an open reading frame of 1866 bp encoding a protein with a predicted size of 72 Kd, which is in keeping with its size on Western blotting. A single 6.2-kb EMT mRNA and 72-Kd protein were detected in T lymphocytes and NK-like cell lines, but were not detected in other cell lineages. EMT contains both SH2 and SH3 domains, as do many other intracellular kinases. EMT does not contain the N-terminal myristylation site or the negative regulatory tyrosine phosphorylation site in its carboxyterminus that are found in the SRC family of tyrosine kinases. EMT is related to the B-cell progenitor kinase (BPK), which has recently been implicated in X-linked hypogammaglobulinemia, to the TECI mammalian kinase, which has been implicated in liver neoplasia, to the more widely expressed TECII mammalian kinase, and to the Drosophila melanogaster Dsrc28 kinase. Sequence comparison suggests that EMT is likely the human homologue of a recently identified murine interleukin-2 (IL-2)-inducible T cell kinase (ITK). However, unlike ITK, EMT message and protein levels do not vary markedly on stimulation of human IL-2-responsive T cells with IL-2. Taken together, it seems that EMT is a member of a new family of intracellular kinases that includes BPK, TECI, and TECII. EMT was localized to chromosome 5q31-32, a region that contains the genes for several growth factors and receptors as well as early activation genes, particularly those involved in the hematopoietic system. Furthermore, the 5q31-32 region is implicated in the genesis of the 5q- syndrome associated with myelodysplasia and development of leukemia.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364206

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Disrupting the intermolecular self-association of Itk enhances T cell signaling.

Authors:  Lie Min; Wenfang Wu; Raji E Joseph; D Bruce Fulton; Leslie Berg; Amy H Andreotti
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

Review 2.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

3.  Antiviral immune responses in Itk-deficient mice.

Authors:  M F Bachmann; D R Littman; X C Liao
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.

Authors:  R N Haire; Y Ohta; S J Strong; R T Litman; Y Liu; J T Prchal; M D Cooper; G W Litman
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  The murine form of TXK, a novel TEC kinase expressed in thymus maps to chromosome 5.

Authors:  R N Haire; G W Litman
Journal:  Mamm Genome       Date:  1995-07       Impact factor: 2.957

6.  FMS hemizygosity in myeloid dysplasia and acute myeloid leukemia with chromosomal aberration del(5)(q) demonstrated by polymerase chain reaction.

Authors:  M Pfeilstöcker; R Grill; E Koller; O Krieger; E Pittermann; H Karlic
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

7.  Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.

Authors:  S Gibson; K Truitt; Y Lu; R Lapushin; H Khan; J B Imboden; G B Mills
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

8.  Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCgamma1.

Authors:  Lie Min; Raji E Joseph; D Bruce Fulton; Amy H Andreotti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

9.  Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.

Authors:  Kirsten Huck; Oliver Feyen; Tim Niehues; Franz Rüschendorf; Norbert Hübner; Hans-Jürgen Laws; Tanja Telieps; Stefan Knapp; Hans-Heinrich Wacker; Alfons Meindl; Hassan Jumaa; Arndt Borkhardt
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

10.  Functional analysis of the T-cell-restricted protein tyrosine kinase Txk.

Authors:  J H Ellis; R P Sutmuller; M J Sims; S Cooksley
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.